ALNYLAM PHARMACEUTICALS, INC.: revenue
| Value | {"amount": 492853000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | superseded |
| Entity | ALNYLAM PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:51:50.761763+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0c6f0418-4eaf-4e79-b38c-20d9b0851740
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001178670-21-000010Retrieved: 2026-08-19T11:51:50.761763+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001178670/revenue/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0c6f0418-4eaf-4e79-b38c-20d9b0851740
History
- no predecessors — first report